India, Oct. 31 -- What are the current challenges faced by the bulk drug manufacturers in India?

Bulk drug manufacturers in India face several challenges, including constantly evolving domestic and international regulatory requirements, intense competition from China, and limited availability of land for expansion. Additionally, rising input costs and environmental compliance pressures further strain operational margins.

Competition from China is significant in the case of APIs. What are your plans to mitigate the crises?

Competition from China is not new. Due to industry-friendly policies and large-scale manufacturing capacities, China has become a dominant player in API production. However, the Indian government has taken steps to st...